Published in Behav Neurosci on June 01, 1999
Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature (2011) 4.13
Molecular specificity of multiple hippocampal processes governing fear extinction. Rev Neurosci (2010) 1.17
Nicotine enhances both foreground and background contextual fear conditioning. Neurosci Lett (2005) 1.13
Identification of genes expressed in the amygdala during the formation of fear memory. Learn Mem (2001) 1.07
Acute ethanol has biphasic effects on short- and long-term memory in both foreground and background contextual fear conditioning in C57BL/6 mice. Alcohol Clin Exp Res (2007) 0.98
Contribution of mGluR5 to pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion. Nat Neurosci (2015) 0.96
Protein synthesis inhibitors, gene superinduction and memory: too little or too much protein? Neurobiol Learn Mem (2007) 0.93
Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav Brain Res (2008) 0.92
p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide. J Neurochem (2011) 0.86
A parametric analysis of factors affecting acquisition and extinction of contextual fear in C57BL/6 and DBA/2 mice. Behav Processes (2012) 0.82
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J (1988) 3.26
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature (1982) 2.44
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature (1986) 2.29
Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci (1999) 2.20
Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet (2000) 1.90
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A (1981) 1.78
Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci U S A (1988) 1.70
Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology (1982) 1.58
Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A (1983) 1.58
Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behav Brain Res (1999) 1.53
Relationship between fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J Neurosci (1998) 1.49
Production of an epidermal growth factor receptor-related protein. Science (1984) 1.46
Phosphorylated cAMP response element binding protein in the mouse brain after fear conditioning: relationship to Fos production. Brain Res Mol Brain Res (2001) 1.37
Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc Natl Acad Sci U S A (1987) 1.37
Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry (1981) 1.35
Production of the Fos protein after contextual fear conditioning of C57BL/6N mice. Brain Res (1998) 1.34
Isolation and characterization of somatostatin from pigeon pancreas. Proc Natl Acad Sci U S A (1979) 1.34
In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology (1982) 1.32
Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models. Mol Psychiatry (2010) 1.28
Purification and partial characterization of inhibin from porcine follicular fluid. Biochem Biophys Res Commun (1985) 1.27
Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A (1983) 1.26
Characterization of rat hypothalamic growth hormone-releasing factor. Nature (1983) 1.24
Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc Natl Acad Sci U S A (1998) 1.23
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet (1983) 1.23
Evidence for the existence of a biosynthetic precursor for somatostatin. Diabetes (1979) 1.22
Generalization of fear responses in C57BL/6N mice subjected to one-trial foreground contextual fear conditioning. Behav Brain Res (1998) 1.19
Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology (1982) 1.19
Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci U S A (1986) 1.16
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14
High-resolution 3D MRI of mouse brain reveals small cerebral structures in vivo. J Neurosci Methods (2002) 1.10
Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol Psychiatry (2004) 1.08
Phosphorylation of high mobility group protein 14 by casein kinase II. J Biol Chem (1985) 1.07
Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci (1982) 1.03
Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behav Neurosci (1997) 1.03
Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. J Neurochem (1999) 1.01
Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology (1983) 1.01
Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism. J Neurosci Res (1996) 0.99
Multiple forms of somatostatin-like activity in rat hypothalamus. Biochemistry (1980) 0.98
Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res (1998) 0.98
The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc Natl Acad Sci U S A (1997) 0.96
Primary structure and functional expression of a glutaminyl cyclase. Proc Natl Acad Sci U S A (1991) 0.96
Post-training injections of catecholaminergic drugs do not modulate fear conditioning in rats and mice. Neurosci Lett (2001) 0.95
Investigation of larger forms of somatostatin in pigeon pancreas and rat brain. Metabolism (1978) 0.95
Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors Channels (2002) 0.95
Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J Neurosci (2000) 0.95
Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab (1982) 0.94
Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor. Biochemistry (1982) 0.93
Comparison of the biologic actions of corticotropin-releasing factor and sauvagine. Regul Pept (1982) 0.93
Isolation and characterization of somatostatin from anglerfish pancreatic islet. Endocrinology (1979) 0.93
Primary structure and tissue distribution of anglerfish carboxypeptidase H. Mol Cell Endocrinol (1991) 0.93
Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5' untranslated region. Mol Pharmacol (2001) 0.92
Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron (1995) 0.91
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Sci (2001) 0.91
Evidence fore biosynthesis and differential post-translational proteolytic processing of different (pre)prosomatostatins in pancreatic islets. J Biol Chem (1983) 0.91
Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs. Peptides (2001) 0.89
Phosphorylation of high mobility group 14 protein by cyclic nucleotide-dependent protein kinases. J Biol Chem (1982) 0.89
A synthetic glucagon-like peptide-1 analog with improved plasma stability. J Endocrinol (1998) 0.89
Molecular Properties of the CRF Receptor. Trends Endocrinol Metab (2008) 0.89
Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor. Brain Res Mol Brain Res (1997) 0.89
The anglerfish somatostatin-28-generating propeptide converting enzyme is an aspartyl protease. Endocrinology (1991) 0.89
Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments. Neuropharmacology (2001) 0.89
Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet (1983) 0.89
Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling. Proc Natl Acad Sci U S A (1996) 0.88
Actions of CRF and its analogs. Curr Med Chem (1999) 0.88
Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution. Eur J Biochem (1998) 0.88
Cloning and structure of the gene encoding the human N-methyl-D-aspartate receptor (NMDAR1). Gene (1995) 0.87
Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract. Allergy (1979) 0.87
Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice. Neuroscience (2005) 0.87
Sequence analysis of rat hypothalamic corticotropin-releasing factor with the o-phthalaldehyde strategy. Biochemistry (1983) 0.87
A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists. Proc Natl Acad Sci U S A (2001) 0.87
Identification of a somatostatin-14-generating propeptide converting enzyme as a member of the kex2/furin/PC family. Endocrinology (1991) 0.86
Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor. J Neurochem (1997) 0.85
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proc Natl Acad Sci U S A (1998) 0.85
Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system. Mol Psychiatry (2008) 0.84
Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism (1990) 0.84
Structural heterogeneity of the alpha subunits of the nicotinic acetylcholine receptor in relation to agonist affinity alkylation and antagonist binding. Biochemistry (1986) 0.84
Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. Endocrinology (2006) 0.84
Comparison of prohormone-processing activities in islet microsomes and secretory granules: evidence for distinct converting enzymes for separate islet prosomatostatins. J Cell Biol (1984) 0.84
Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning. Neuropharmacology (2000) 0.83
Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J Neurochem (1997) 0.83
Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J Immunol (1999) 0.83
Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav Brain Res (2000) 0.83